Ann M Wanner, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3901 Hoyt Ave, Everett, WA 98201 Phone: 425-259-0966 |
James C Bommarito, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 3901 Hoyt Ave, Everett, WA 98201 Phone: 425-259-0966 |
Paul T Mcbride, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3901 Hoyt Ave, Everett, WA 98201 Phone: 425-259-0966 |
Michael S Kennedy, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 3901 Hoyt Ave, Everett, WA 98201 Phone: 425-339-5412 Fax: 425-259-1164 |
Amy Brookman, PA-C Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 3125 Colby Ave Ste J, Everett, WA 98201 Phone: 425-791-3093 Fax: 425-791-3094 |
August Jillian Generoso, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3901 Hoyt Ave, Everett, WA 98201 Phone: 425-339-5412 Fax: 425-259-1164 |
News Archive
Through the publication of its Consensus Statement on the Management of High Blood Pressure in Blacks in this week's issue of Hypertension, ISHIB today released new recommendations recognizing that high blood pressure among African Americans is a severe health problem. The consensus statement suggests that treatment should start sooner and be more aggressive among African Americans.
Porous ceramic water filters are often coated with colloidal silver, which prevents the growth of microbes trapped in the micro- and nano-scale pores of the filter. Other metals such as copper and zinc have also been shown to exhibit anti-microbial activity.
A protein with a role in sensing cell damage and viral infections is a new target for the treatment of pulmonary hypertension, or increased blood pressure in the lungs, according to research led by Virginia Commonwealth University and the University of Sheffield in the United Kingdom.
Biocept, Inc., a leading commercial provider of clinically actionable liquid biopsy tests designed to improve the outcomes of cancer patients, announces that Columbia University Medical Center will conduct a study to evaluate the clinical utility of the Company's Target Selectorâ„¢ platform to diagnose leptomeningeal metastases (LM) in patients with breast cancer.
› Verified 2 days ago